113 related articles for article (PubMed ID: 17228174)
1. Involvement of transglutaminase-2 in pathological changes in renal disease.
Ikee R; Kobayashi S; Hemmi N; Saigusa T; Namikoshi T; Yamada M; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Nephron Clin Pract; 2007; 105(3):c139-46. PubMed ID: 17228174
[TBL] [Abstract][Full Text] [Related]
2. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
Rong ZH; Wang C; Hao J; Duan HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
[TBL] [Abstract][Full Text] [Related]
4. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
[TBL] [Abstract][Full Text] [Related]
5. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy.
Widstam-Attorps U; Berg U; Bohman SO; Lefvert AK
Clin Nephrol; 1992 Nov; 38(5):245-53. PubMed ID: 1451337
[TBL] [Abstract][Full Text] [Related]
6. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
7. Pattern of renal beta 1(alpha 1-alpha 6) integrins distribution in IgA nephropathy and Henoch-Schoenlein nephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(2):51-7. PubMed ID: 12140867
[TBL] [Abstract][Full Text] [Related]
8. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
Tomioka M; Hiromura K; Sakairi T; Takeuchi S; Maeshima A; Kaneko Y; Kuroiwa T; Takeuchi T; Nojima Y
Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
[TBL] [Abstract][Full Text] [Related]
9. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2002; 53(3):155-62. PubMed ID: 12476618
[TBL] [Abstract][Full Text] [Related]
10. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
Paydas S; Balal M; Tanriverdi K; Sertdemir Y; Baslamisli F
Ren Fail; 2007; 29(7):779-84. PubMed ID: 17994443
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
Ikee R; Kobayashi S; Saigusa T; Namikoshi T; Yamada M; Hemmi N; Imakiire T; Kikuchi Y; Suzuki S; Miura S
Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
[TBL] [Abstract][Full Text] [Related]
13. Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
Arikan H; Koc M; Cakalagaoglu F; Tuglular S; Ozener C; Akoglu E
Nephrology (Carlton); 2009 Apr; 14(2):219-26. PubMed ID: 19298642
[TBL] [Abstract][Full Text] [Related]
14. Glomerulo-tubular junction stenosis as a factor contributing to glomerular obsolescence in IgA nephropathy.
Sato M; Hotta O; Taguma Y
J Pathol; 2002 May; 197(1):14-9. PubMed ID: 12081198
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.
Sakamoto-Ihara T; Suzuki Y; Kurusu A; Yamashita M; Horikoshi S; Tomino Y
Inflamm Res; 2007 Oct; 56(10):421-7. PubMed ID: 18026699
[TBL] [Abstract][Full Text] [Related]
16. Histological differences in new-onset IgA nephropathy between children and adults.
Ikezumi Y; Suzuki T; Imai N; Ueno M; Narita I; Kawachi H; Shimizu F; Nikolic-Paterson DJ; Uchiyama M
Nephrol Dial Transplant; 2006 Dec; 21(12):3466-74. PubMed ID: 16935895
[TBL] [Abstract][Full Text] [Related]
17. Tenascin expression may reflect the activity and chronicity of human IgA nephropathy.
Masaki T; Yorioka N; Taniguchi Y; Oda H; Yamakido M
Clin Nephrol; 1998 Oct; 50(4):205-13. PubMed ID: 9799064
[TBL] [Abstract][Full Text] [Related]
18. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
[TBL] [Abstract][Full Text] [Related]
19. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
20. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
Jeong HJ; Park SK; Cho YM; Kim MS; Kim YS; Choi J; Kim SI; Lim BJ
Hum Pathol; 2008 Oct; 39(10):1511-8. PubMed ID: 18620732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
